Actively Recruiting
Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation.
Led by Biosency · Updated on 2024-08-15
30
Participants Needed
1
Research Sites
84 weeks
Total Duration
On this page
Sponsors
B
Biosency
Lead Sponsor
R
Rennes University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to assess the feasibility of early detection of acute exacerbations of idiopathic pulmonary fibrosis by the remote monitoring of vital signs. The main question the study aims to answer is: Could a remote monitoring device allow for earlier detection of exacerbations with individualized monitoring and continuous data collection? All patients will receive conventional clinical follow-up based on their health status and clinical recommendations. At the same time, they will benefit from the Bora Care® medical remote monitoring device.
CONDITIONS
Official Title
Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient over 18 years of age, ideally 50% male and 50% female
- Patient with IPF with a known level of respiratory function (EFR and blood gas less than 3 months)
- Stable patient, i.e. without hospitalisation or exacerbation in the last 3 months
- Patient desaturating at 6MW in ambient air (AA) and requiring ambulatory oxygen therapy (SpO2 AA 88%)
- Patient not receiving walking or permanent oxygen therapy at baseline
- Informed patient who has signed consent
- Patient affiliated to a social security scheme
- Patient not monitored by a home healthcare provider other than Air de Bretagne.
You will not qualify if you...
- Vulnerable patient
- Patient receiving ambulatory or permanent oxygen therapy at baseline
- Patient already seen with another healthcare provider (e.g. OSAS)
- Patient unable to use the Bora Band4 tool and without access to a caregiver
- Presence of co-morbidity considered unstable or very severe by the investigator
- Patient protected, under guardianship or incapable of giving free and informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chru Pontchaillou
Rennes, France, 35000
Actively Recruiting
Research Team
A
Alexis TOULLEC
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here